カイダ ケンイチ
KAIDA Kenichi
海田 賢一 所属 埼玉医科大学 医学部 総合医療センター 脳神経内科 職種 教授 |
|
論文種別 | 学術雑誌(原著) |
言語種別 | 英語 |
査読の有無 | 査読なし |
表題 | ABCG2 variant has opposing effects on onset ages of Parkinson's disease and gout. |
掲載誌名 | 正式名:Annals of clinical and translational neurology |
巻・号・頁 | 2(3),302-6頁 |
著者・共著者 | Hirotaka Matsuo,Hiroyuki Tomiyama,Wataru Satake,Toshinori Chiba,Hiroyuki Onoue,Yusuke Kawamura,Akiyoshi Nakayama,Seiko Shimizu,Masayuki Sakiyama,Manabu Funayama,Kenya Nishioka,Toru Shimizu,Kenichi Kaida,Keiko Kamakura,Tatsushi Toda,Nobutaka Hattori,Nariyoshi Shinomiya |
発行年月 | 2015/03 |
概要 | Uric acid (urate) has been suggested to play a protective role in Parkinson's disease onset through its antioxidant activity. Dysfunction of ABCG2, a high-capacity urate exporter, is a major cause for early-onset gout based on hyperuricemia. In this study, the effects of a dysfunctional ABCG2 variant (Q141K, rs2231142) were analyzed on the ages at onset of gout patients (N = 507) and Parkinson's disease patients (N = 1015). The Q141K variant hastened the gout onset (P = 0.0027), but significantly associated with later Parkinson's disease onset (P = 0.025). Our findings will be helpful for development of more effective prevention of Parkinson's disease. |
DOI | 10.1002/acn3.167 |
PMID | 25815357 |